Global Penicillin Active Pharmaceutical Ingredients Market Research Report 2021

Penicillin refers to a class of antibiotics containing penicillin in the molecule, which can destroy the cell wall of bacteria and play a bactericidal role in the breeding period of bacterial cells. It is an antibiotic extracted from Penicillium. Penicillin belongs to β-lactam antibiotics, and β-lactam antibiotics include penicillin, cephalosporin, carbapenems, monocyclic, and cephalosporins. Penicillin is a very common antibacterial drug. However, an intradermal test must be performed before each use to prevent allergies.
This report focuses on Penicillin Active Pharmaceutical Ingredients.
Global key players of Penicillin Active Pharmaceutical Ingredients include United Laboratories, Changsheng Pharma, North China Pharmaceutical, Centrient Pharmaceuticals, Aurobindo Pharma and Sinopharm Weiqida Pharmaceutical, etc. Top five players occupy for a share about 50%. Asia-Pacific is the largest market, with a share about 60%, followed by Americas and Europe. In terms of product, Amoxicillin is the largest segment, with a share over 76%. In terms of application, For Oral is the largest market, with a share over 73%.

The global Penicillin Active Pharmaceutical Ingredients market was valued at US$ 1948.4 million in 2020 and is expected to reach US$ 1681 million by the end of 2027, growing at a CAGR of -1.4% during 2021-2027.
This report focuses on Penicillin Active Pharmaceutical Ingredients volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Penicillin Active Pharmaceutical Ingredients market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Penicillin Active Pharmaceutical Ingredients Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Amoxicillin
Piperacillin
Benzylpenicillin Sodium
Ampicillin
Other

Segment by Application
For Oral
For Injection

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Centrient Pharmaceuticals
Jiangxi Fushine Pharmaceutical
Kelun
Harbin Pharmaceutical Group
Changzhou RedSun
Jiangxi Huabang
LKPC
Huaxing Pharma
North China Pharmaceutical
Qilu Tianhe Pharma
Novartis (Sandoz Anti-Infectives)
CSPC Zhongrun
United Laboratories
Sinopharm Weiqida Pharmaceutical
Changsheng Pharma
Aurobindo Pharma
Novartis
ACS Dobfar

Frequently Asked Questions